ESC Premium Access

Progress in anticoagulation for venous thromboembolism

Event: ESC Congress 2018
Topic: Treatment
Session type: Advances in Science
Date: 27 August 2018
Time: 16:45 - 17:45


4 presentations in this session

State of the Art - Optimizing the prevention of venous thromboembolism

Speaker: Professor A. Spyropoulos (New York, US)

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Speaker: Doctor Y. Yamashita (Kyoto, JP)

Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Speaker: Doctor E. Klok (Leiden, NL)

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)

4 speakers from this session

Professor Alex Spyropoulos

Northwell Health, New York (United States of America)
4 presentations
0 follower

Doctor Yugo Yamashita

Kyoto University Graduate School of Medicine, Kyoto (Japan)
1 presentation
0 follower

Doctor Erik Klok

Leiden University Medical Centre, Leiden (Netherlands (The))
3 presentations
0 follower

Doctor Arzu Kalayci Karabay

Harvard Medical School, Boston (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk